M. Janiszewska
Molecular Biology · 2020
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 24 citations into it
- Cancer Research — 22 citations into it
Whom M. Janiszewska trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from M. Janiszewska's perspective
Ordered by how strongly the researchers M. Janiszewska trusts endorse each paper. Same corpus, a different order for every researcher.
- A chromatin-mediated reversible drug tolerant state in cancer cell subpopulations (Cell)
- Mutational landscape and significance across 12 major cancer types (Nature)
- A microenvironmental model of carcinogenesis (Nature Reviews. Cancer)
- The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy (Nature Reviews. Cancer)
- Cancer immunotherapy using checkpoint blockade (Science)
- Signatures of mutational processes in human cancer (Nature)
- Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer (Cancer Discovery)
- Multiplexed ion beam imaging (MIBI) of human breast tumors (Nature Medicine)
- Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer (Nature)
- Tracking the Evolution of Non‐Small‐Cell Lung Cancer (New England Journal of Medicine)
Their papers
- Intratumor heterogeneity: the Rosetta stone of therapy resistance (2020) — 807 citations